Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
about
The EMPA-REG outcome study: critical appraisal and potential clinical implicationsMetabolic syndrome and the hepatorenal reflexApolipoprotein E gene polymorphisms are associated with primary hyperuricemia in a Chinese populationSerum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study.Serum Uric Acid, Kidney Function and Acute Ischemic Stroke Outcomes in Elderly Patients: A Single-Cohort, Perspective Study.Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studiesFructose and uric acid: is there a role in endothelial function?Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats.Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study.Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?Prevalence and risk factors associated with prehypertension in Shunde District, southern China.Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus.Association of thyroid hormones with obesity and metabolic syndrome in Japanese children.Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of NephropathyAssociation of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components.Obesity-related metabolite profiles of black women spanning the epidemiologic transition.Gene-alcohol interactions identify several novel blood pressure loci including a promising locus near SLC16A9.Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.Metabolic syndrome and the hepatorenal reflex.Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders.Dietary and commercialized fructose: Sweet or sour?Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression.Hyperuricaemia in patients with type 2 diabetes in a tertiary healthcare centre in sub-Saharan Africa: prevalence and determinants.Ideal Cardiovascular Health Metrics and Incident Hyperuricemia.Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.Development of a PrGO-Modified Electrode for Uric Acid Determination in the Presence of Ascorbic Acid by an Electrochemical Technique.The prevalence, subtypes and associated factors of hyperuricemia in lupus nephritis patients at chronic kidney disease stages 1-3.Associations of estimated glomerular filtration rate and blood urea nitrogen with incident coronary heart disease: the Dongfeng-Tongji Cohort Study.Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease.Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort studyUric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China.Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.High-normal estimated glomerular filtration rate and hyperuricemia positively correlate with metabolic impairment in pediatric obese patients.Association Between Uric Acid and Metabolic Syndrome in Elderly Women.Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice.Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout.
P2860
Q26748742-62FFA0CF-886D-4834-ADB8-E81EA1A9BE91Q28073645-82EE74C0-CE5F-4F12-B3B3-15EF1F3EBA01Q28544622-7F0A4D81-FFBA-4414-950B-356E6318DF44Q30691881-2E813C61-4515-4EBD-BD3B-A81929DFA4B3Q33564198-2A33BFB4-E411-47A3-A9FB-34D183292B29Q33770852-966CFE27-2CEA-44CE-93E6-F9CE9A253824Q33854358-6ACD930A-53A5-4809-9853-E7074B4F4ED0Q34128253-C11345CF-9348-4CBA-AC62-BEF46F9F8A51Q34400445-21D5A854-384E-4650-B075-0FECC6B2F595Q34538414-22A51A19-5B4F-4160-95DE-8463C5961E18Q34573013-6D03B067-9C35-4BBC-B89E-0F95285B07EDQ34658560-A54F2438-CC54-4763-B7A2-314226779489Q35017383-D2D99EFE-1559-44FA-B3C4-E6DD6B6F7C4FQ36049100-BFEE2C6B-635B-466B-A603-61883141FAAEQ36189989-564ABFD1-074B-439E-9465-6A0A7E9EE8E9Q36373688-B1D89693-1ABF-493D-87C8-CA155AC42222Q36650743-78ED3AEF-5EB5-4321-9AFC-EC052C8BD3EDQ37025089-C41B3A1F-4EED-423C-A789-262C59D16971Q37385974-1923D013-0D1E-4DD5-894D-CFC53B3C99C9Q37447055-85CECF2D-1257-4D1A-8DCD-EDCDE3C71222Q37604638-9F177587-D541-46D6-824B-2FBFBA498DE8Q38494677-77C48DBC-DA36-44AD-89EE-078D9085B463Q38522643-026D5C92-4121-4A73-ABD6-E2CD2BF27C29Q39140257-CC3B889A-8DDB-48A0-93F3-1A6710AF71AAQ39377539-D38AD4DF-84B3-43DE-AD82-FC0A53693E2DQ40101002-E04FB847-1A36-47AD-91C3-E268447BBD71Q41013668-01A23FCE-6B5A-4BC0-810E-5A33CFB78DA2Q41202631-5AA60844-9597-4ECB-9AF7-A269CA1CD177Q41205965-935D002C-C3F4-4325-BD1C-D53271B8B71AQ41343048-C858E2CD-7571-4932-8A23-1E7D958A5216Q41564978-EF84B8E2-A185-4E4B-8A7B-2FBAA6325270Q41986990-AFFF170F-10B9-4D56-8735-4A05B9F024ECQ42100260-B1899F5A-4ADA-4073-B88C-823B8AB00FBCQ45141589-62E1D8CB-13FC-43E6-8226-D0800E51303CQ47672033-48A85FBF-00A3-457F-A9C3-5A53CF83F9A6Q52601559-BBF5F0EA-5F4F-4FD2-94AC-E7CB7018D2C9Q53704628-21CC5610-EAFB-4C80-86C4-F653170B6069Q53821752-80114FA9-E04B-4729-8D64-D5C64EFE9161Q54090447-857CDE2D-8C7D-4E2B-AF2D-D4BA16302F2EQ55347253-966BCEAF-C142-4A2F-B1AD-F62EED82AA2A
P2860
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential role of uric acid in ...... s: is it time for reappraisal?
@en
Potential role of uric acid in ...... s: is it time for reappraisal?
@nl
type
label
Potential role of uric acid in ...... s: is it time for reappraisal?
@en
Potential role of uric acid in ...... s: is it time for reappraisal?
@nl
prefLabel
Potential role of uric acid in ...... s: is it time for reappraisal?
@en
Potential role of uric acid in ...... s: is it time for reappraisal?
@nl
P2093
P2860
P921
P1476
Potential role of uric acid in ...... s: is it time for reappraisal?
@en
P2093
Daniel R Kapusta
Efrain Reisin
Kashaf Rasheed
Zohreh Soltani
P2860
P2888
P304
P356
10.1007/S11906-013-0344-5
P577
2013-06-01T00:00:00Z